EX-1 2 a05-2856_3ex1.htm EX-1

EXHIBIT 1

 

DECLARATION OF CONSENT TO JOINT FILING BY SANOFI-AVENTIS, AVENTIS PHARMACEUTICALS INC, AVENTIS HOLDINGS INC AND AVENTIS INC.

 

WHEREAS, in accordance with Rule 13d-1(k) under the Securities and Exchange Act of 1934 (the “Act”), only one joint statement and any amendments thereto need to be filed whenever one or more persons are required to file such a statement or any amendments thereto pursuant to Section 13(d) of the Act with respect to the same securities, provided that said persons agree in writing that such statement or amendments thereto is filed on behalf of each of them;

 

NOW, THEREFORE, the parties hereto agree as follows:

 

Sanofi-aventis, Aventis Pharmaceuticals Inc, Aventis Holdings Inc and Aventis Inc. hereby agree, in accordance with Rule 13d-1(k) under the Act, to file a statement on Schedule 13G relating to their ownership of the Common Stock of the Issuer and do hereby further agree that said statement shall be filed on behalf of each of them.

 

 

 

SANOFI-AVENTIS.

 

 

 

 

Date: February 8, 2005

By:

/s/ Jean-Claude Leroy

 

 

Jean-Claude LEROY

 

Chief Financial Officer

 

 

 

 

 

AVENTIS PHARMACEUTICALS
INC.

 

 

 

 

Date: February 8, 2005

By:

/s/ John M. Spinnato

 

 

John M. SPINNATO

 

Vice President and General Counsel
- Pharmaceutical Operations

 

 

 

 

 

AVENTIS HOLDINGS INC.

 

 

 

 

Date: February 8, 2005

By:

/s/ Joseph M. Palladino

 

 

Joseph M. PALLADINO

 

President

 

 

 

 

 

AVENTIS INC.

 

 

 

 

Date: February 8, 2005

By:

/s/ Joseph Haggerty

 

 

Joseph HAGGERTY

 

Vice President and General Counsel